. Récidive,

. Récidive, EP Information manquante 440 94 (21,4%) 94 (21,4%) Dyspnée persistante, n (%) Information manquante, vol.478, p.6

N. Classe, Information manquante 478 29 (6,6%) 215 (48,8%) Anticoagulation long cours, n (%) Information manquante, vol.3, p.8

. Décès, 8%) 119 (24,9%) HTAP post-embolique, n (%) Information manquante 478 21 (4,8%) 234 (53,2%) Délai jusqu'à récidive, vol.478, p.61

R. H. White, ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)Endorsed by the, Circulation, vol.107, issue.2, pp.4-8, 2003.

, Eur Heart J, vol.35, pp.3033-73, 2014.

I. A. Naess, S. C. Christiansen, P. Romundstad, S. C. Cannegieter, and F. R. Rosendaal,

J. Hammerstrøm, Incidence and mortality of venous thrombosis: a population-based study, J Thromb Haemost, vol.5, pp.692-701, 2007.

T. Ohira, M. Cushman, and M. Y. Tsai, ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE), J Thromb Haemost, vol.5, pp.1455-61, 2007.

M. M. Samama, A. T. Cohen, and J. Darmon, A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients, N Engl J Med, vol.341, pp.793-800, 1999.

M. Rogers, D. A. Levine, N. Blumberg, S. A. Flanders, V. Chopra et al., Triggers of hospitalization for venous thromboembolism, Circulation, vol.125, pp.2092-2101, 2012.

E. Ferrari, T. Chevallier, A. Chapelier, and M. Baudouy, Travel as a risk factor for venous thromboembolic disease: a case-control study, Chest, vol.115, pp.440-444, 1999.

H. K. Chew, T. Wun, D. Harvey, H. Zhou, and R. H. White, Incidence of venous thromboembolism and its effect on survival among patients with common cancers, Arch Intern Med, vol.166, pp.458-64, 2006.

P. Prandoni, F. Bilora, and A. Marchiori, An association between atherosclerosis and venous thrombosis, N Engl J Med, vol.348, pp.1435-1476, 2003.

G. Piazza and S. Z. Goldhaber, Venous thromboembolism and atherothrombosis: an integrated approach, Circulation, vol.121, pp.2146-50, 2010.

W. Ageno, C. Becattini, T. Brighton, R. Selby, and P. W. Kamphuisen, Cardiovascular risk factors and venous thromboembolism: a meta-analysis, Circulation, vol.117, pp.93-102, 2008.

K. F. Enga, S. K. Braekkan, I. J. Hansen-krone, S. Le-cessie, F. R. Rosendaal et al.,

, Cigarette smoking and the risk of venous thromboembolism: the Tromsø Study, J Thromb Haemost, vol.10, pp.2068-74, 2012.

M. T. Severinsen, S. R. Kristensen, S. P. Johnsen, C. Dethlefsen, A. Tjønneland et al.,

, Smoking and venous thromboembolism: a Danish follow-up study, J Thromb Haemost, vol.7, pp.1297-303, 2009.

C. Parker, C. Coupland, and J. Hippisley-cox, Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception, Lancet, vol.341, pp.1575-82, 1995.

S. Sweetland, V. Beral, and A. Balkwill, Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study, J Thromb Haemost, vol.10, pp.2277-86, 2012.

E. R. Pomp, A. M. Lenselink, F. R. Rosendaal, and C. Doggen, Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study, J Thromb Haemost, vol.6, pp.632-639, 2008.

P. Henriksson, E. Westerlund, H. Wallén, L. Brandt, O. Hovatta et al., Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study, BMJ, vol.346, p.8632, 2013.

E. Thaler and K. Lechner, Antithrombin III deficiency and thromboembolism, Clin Haematol, vol.10, pp.369-90, 1981.

M. Den-heijer, T. Koster, and H. J. Blom, Hyperhomocysteinemia as a risk factor for deepvein thrombosis, N Engl J Med, vol.334, pp.759-62, 1996.

B. M. Wolpin, C. Kabrhel, and R. Varraso, Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies, Thromb Haemost, vol.104, pp.962-71, 2010.

T. Ohira, M. Cushman, and M. Y. Tsai, ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE), J Thromb Haemost, vol.5, pp.1455-61, 2007.

A. Leader, D. Pereg, and M. Lishner, Are platelet volume indices of clinical use? A multidisciplinary review, Ann Med, vol.44, pp.805-821, 2012.

S. K. Braekkan, E. B. Mathiesen, I. Njølstad, T. Wilsgaard, J. Størmer et al., Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, J Thromb Haemost, vol.8, pp.157-62, 2010.

G. Slavka, T. Perkmann, and H. Haslacher, Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease, Arterioscler Thromb Vasc Biol, vol.31, pp.1215-1223, 2011.
DOI : 10.1161/atvbaha.110.221788

URL : https://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.110.221788

P. Bath, C. Algert, N. Chapman, and B. Neal,

R. Simanek, R. Vormittag, and C. Ay, High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS), J Thromb Haemost, vol.8, pp.114-134, 2010.

A. W. Tsai, M. Cushman, and W. D. Rosamond, Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE), Am J Med, vol.113, pp.636-678, 2002.

D. Khemasuwan, Y. K. Chae, and S. Gupta, Dose-related effect of statins in venous thrombosis risk reduction, Am J Med, vol.124, pp.852-861, 2011.

S. Schulman, C. Kearon, and A. K. Kakkar, Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism, N Engl J Med, vol.361, pp.2342-52, 2009.
URL : https://hal.archives-ouvertes.fr/ujm-00439704

, Oral Rivaroxaban for Symptomatic Venous Thromboembolism, N Engl J Med, vol.363, pp.2499-510, 2010.

G. Agnelli, H. R. Buller, and A. Cohen, Oral Apixaban for the Treatment of Acute Venous Thromboembolism, N Engl J Med, vol.369, pp.799-808, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00932477

, The Hokusai-VTE Investigators. Edoxaban versus Warfarin for the Treatment of

, Symptomatic Venous Thromboembolism, N Engl J Med, vol.369, pp.1406-1421, 2013.

G. E. Raskob, N. Van-es, and P. Verhamme, Edoxaban for the Treatment of Cancer

, Associated Venous Thromboembolism, N Engl J Med, vol.378, pp.615-639, 2018.

C. Kearon, A. Iorio, and G. Palareti, Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting: Acceptable venous thromboembolism recurrence rates, J Thromb Haemost, vol.8, pp.2313-2318, 2010.

A. Iorio, C. Kearon, and E. Filippucci, Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review, Arch Intern Med, vol.170, pp.1710-1716, 2010.

J. D. Douketis, C. S. Gu, S. Schulman, A. Ghirarduzzi, V. Pengo et al., The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism, Ann Intern Med, vol.147, pp.766-74, 2007.

M. A. Rodger, L. Gal, G. Anderson, and D. R. , Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study, BMJ, p.1065, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02050942

A. Tosetto, A. Iorio, and M. Marcucci, Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH), J Thromb Haemost, vol.10, pp.1019-1044, 2012.

S. Eichinger, G. Heinze, L. M. Jandeck, and P. A. Kyrle, Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model, Circulation, vol.121, pp.1630-1636, 2010.

T. Zhu, I. Martinez, and J. Emmerich, Venous thromboembolism: risk factors for recurrence

, Arterioscler Thromb Vasc Biol, vol.29, pp.298-310, 2009.

P. Prandoni, F. Noventa, and A. Ghirarduzzi, The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients, Haematologica, vol.92, pp.199-205, 2007.

M. D. Silverstein, J. A. Heit, D. N. Mohr, T. M. Petterson, W. M. O'fallon et al., Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study, Arch Intern Med, vol.158, pp.585-93, 1998.

J. A. Heit, B. D. Lahr, T. M. Petterson, K. R. Bailey, A. A. Ashrani et al., Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study, Blood, vol.118, issue.18, pp.4992-5001, 2011.

P. O. Hansson, J. Sörbo, and H. Eriksson, Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors, Arch Intern Med, vol.160, pp.769-74, 2000.

F. A. Spencer, Patient Outcomes After Deep Vein Thrombosis and Pulmonary

, EmbolismThe Worcester Venous Thromboembolism Study, Arch Intern Med, vol.168, p.425, 2008.

P. A. Kyrle, E. Minar, C. Bialonczyk, M. Hirschl, A. Weltermann et al., The Risk of

, Recurrent Venous Thromboembolism in Men and Women, N Engl J Med, vol.350, pp.2558-63, 2004.

T. Baglin, R. Luddington, K. Brown, and C. Baglin, High risk of recurrent venous thromboembolism in men, J Thromb Haemost JTH, vol.2, pp.2152-2157, 2004.

L. N. Roberts, R. K. Patel, and R. Arya, Venous thromboembolism and ethnicity, Br J Haematol, vol.146, pp.369-83, 2009.

J. A. Heit, D. N. Mohr, M. D. Silverstein, T. M. Petterson, W. M. O'fallon et al., Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study, Arch Intern Med, vol.160, pp.761-769, 2000.

L. Eischer, S. Eichinger, and P. A. Kyrle, Age at first venous thromboembolism and risk of recurrence: a prospective cohort study, Medicine (Baltimore), vol.88, pp.366-70, 2009.
DOI : 10.1097/md.0b013e3181c29e31

C. Tromeur, O. Sanchez, and E. Presles, Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial, Eur Respir J, pp.51-1701202, 2018.
DOI : 10.1183/13993003.01202-2017

URL : https://hal.archives-ouvertes.fr/hal-02059217

G. Hron, S. Eichinger, and A. Weltermann, Family history for venous thromboembolism and the risk for recurrence, Am J Med, vol.119, pp.50-53, 2006.
DOI : 10.1016/j.amjmed.2005.04.043

K. Sundquist, J. Sundquist, P. J. Svensson, B. Zöller, and A. A. Memon, Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective followup study, J Thromb Haemost, vol.13, pp.2180-2186, 2015.

P. Prandoni, Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis, Blood, vol.100, pp.3484-3492, 2002.
DOI : 10.1182/blood-2002-01-0108

URL : http://www.bloodjournal.org/content/100/10/3484.full.pdf

S. Noble and J. Pasi, Epidemiology and pathophysiology of cancer-associated thrombosis
DOI : 10.1038/sj.bjc.6605599

URL : https://www.nature.com/articles/6605599.pdf

, Br J Cancer, vol.102, issue.1, pp.2-9, 2010.

S. Eichinger, G. Hron, and C. Bialonczyk, Overweight, obesity, and the risk of recurrent venous thromboembolism, Arch Intern Med, vol.168, pp.1678-83, 2008.
DOI : 10.1001/archinte.168.15.1678

URL : https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/770355/ioi80062_1678_1683.pdf

B. Linnemann, D. Zgouras, M. Schindewolf, J. Schwonberg, and M. Jarosch-preusche,

E. Lindhoff-last, Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry, Blood Coagul Fibrinolysis Int J Haemost Thromb, vol.19, pp.159-65, 2008.

R. H. White, W. Chan, H. Zhou, and J. S. Ginsberg, Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism, Thromb Haemost, vol.100, pp.246-52, 2008.

L. Gal, G. Kovacs, M. J. Carrier, and M. , Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study, Thromb Haemost, vol.104, pp.498-503, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00722011

M. Ljungqvist, K. Sonnevi, A. Bergendal, M. Holmström, H. Kieler et al., Risk factors for recurrent venous thromboembolism in young and middle-aged women, Thromb Res, vol.133, pp.762-769, 2014.
DOI : 10.1016/j.thromres.2014.02.017

D. Baudouy, P. Moceri, and O. Chiche, B blood group: A strong risk factor for venous thromboembolism recurrence, Thromb Res, vol.136, pp.107-118, 2015.
DOI : 10.1016/j.thromres.2015.05.002

P. Prandoni, F. Noventa, and A. Ghirarduzzi, The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients, Haematologica, vol.92, pp.199-205, 2007.

S. C. Christiansen and . Thrombophilia, Clinical Factors, and Recurrent Venous Thrombotic Events, JAMA, vol.293, p.2352, 2005.

M. H. Prins, A. Lensing, and P. Prandoni, Risk of recurrent venous thromboembolism according to baseline risk factor profiles, Blood Adv, vol.2, pp.788-96, 2018.
DOI : 10.1182/bloodadvances.2018017160

URL : http://europepmc.org/articles/pmc5894264?pdf=render

B. Cosmi, C. Legnani, M. Cini, G. Guazzaloca, and G. Palareti, D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis, Thromb Haemost, vol.105, pp.837-882, 2011.

L. Young, P. Ockelford, D. Milne, V. Rolfe-vyson, S. Mckelvie et al., Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality, J Thromb Haemost, vol.4, pp.1919-1943, 2006.

T. Baglin, J. Douketis, and A. Tosetto, Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis, J Thromb Haemost, vol.8, pp.2436-2478, 2010.

S. Grifoni, S. Vanni, and S. Magazzini, Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events, Arch Intern Med, vol.166, pp.2151-2157, 2006.
DOI : 10.1001/archinte.166.19.2151

URL : https://jamanetwork.com/journals/jamainternalmedicine/articlepdf/411155/ioi60114.pdf

O. Araz, F. S. Albez, E. Y. Ucar, B. Kerget, N. Y?lmaz et al., Predictive Value of Mean Platelet Volume for Pulmonary Embolism Recurrence, Lung, vol.195, pp.497-502, 2017.
DOI : 10.1007/s00408-017-0020-7

J. Trujillo-santos, D. Micco, P. Iannuzzo, and M. , Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry
DOI : 10.1160/th08-05-0339

, Thromb Haemost, vol.100, pp.905-916, 2008.

M. A. Khamashta, M. J. Cuadrado, F. Mujic, N. A. Taub, B. J. Hunt et al., The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome, N Engl J Med, vol.332, pp.993-1000, 1995.

J. De-godoy, M. F. De-godoy, and D. M. Braile, Recurrent thrombosis in patients with deep vein thrombosis and/or venous thromboembolism associated with anticardiolipin antibodies, Angiology, vol.57, pp.79-83, 2006.

D. Garcia, E. A. Akl, R. Carr, and C. Kearon, Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review, Blood, vol.122, pp.817-841, 2013.

S. C. Christiansen, S. C. Cannegieter, T. Koster, J. P. Vandenbroucke, and F. R. Rosendaal,

, Thrombophilia, clinical factors, and recurrent venous thrombotic events, JAMA, vol.293, pp.2352-61, 2005.

S. Eichinger, A. Weltermann, and C. Mannhalter, The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism, Arch Intern Med, vol.162, pp.2357-60, 2002.

S. Eichinger, A. Stümpflen, and M. Hirschl, Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism, Thromb Haemost, vol.80, pp.566-575, 1998.

G. Palareti, B. Cosmi, and C. Legnani, Dimer Testing to Determine the Duration of Anticoagulation Therapy, N Engl J Med, vol.355, pp.1780-1789, 2006.

B. Cosmi, C. Legnani, and A. Tosetto, Sex, age and normal post-anticoagulation Ddimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension, J Thromb Haemost, vol.8, pp.1933-1975, 2010.

S. Eichinger, E. Minar, and C. Bialonczyk, D-dimer levels and risk of recurrent venous thromboembolism, JAMA, vol.290, pp.1071-1075, 2003.
DOI : 10.1001/jama.290.8.1071

URL : https://jamanetwork.com/journals/jama/articlepdf/197151/JBR30251.pdf

B. Cosmi, C. Legnani, and A. Tosetto, Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study, Blood, vol.115, pp.481-489, 2010.

V. Pengo, A. Lensing, and M. H. Prins, Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism, N Engl J Med, vol.350, pp.2257-64, 2004.

Y. M. Ende-verhaar, S. C. Cannegieter, V. Noordegraaf, and A. , Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature, Eur Respir J, pp.49-1601792, 2017.

D. Bonderman, H. Wilkens, and S. Wakounig, Risk factors for chronic thromboembolic pulmonary hypertension, Eur Respir J, vol.33, pp.325-356, 2009.

F. A. Klok, K. W. Van-kralingen, A. Van-dijk, F. H. Heyning, H. W. Vliegen et al.,

, Prevalence and potential determinants of exertional dyspnea after acute pulmonary embolism, Respir Med, vol.104, pp.1744-1753, 2010.

F. Verschuren, M. Bonnet, and M. Benoit, The prognostic value of pro-B-Type natriuretic peptide in acute pulmonary embolism, Thromb Res, vol.131, pp.235-239, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00935984

C. Becattini, M. C. Vedovati, and G. Agnelli, Prognostic value of troponins in acute pulmonary embolism: a meta-analysis, Circulation, vol.116, pp.427-460, 2007.

M. Kayrak, H. I. Erdo?an, and Y. Solak, Prognostic value of neutrophil to lymphocyte ratio in patients with acute pulmonary embolism: a restrospective study, Heart Lung Circ, vol.23, pp.56-62, 2014.

L. M. Mollard, L. Mao, R. Tromeur, and C. , Antipsychotic drugs and the risk of recurrent venous thromboembolism: A prospective cohort study, Eur J Intern Med, vol.52, pp.22-29, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02056408

L. Gallinaro, M. G. Cattini, and M. Sztukowska, A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor, Blood, vol.111, pp.3540-3545, 2008.

J. C. Souto, L. Almasy, and E. Muñiz-diaz, Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time, Arterioscler Thromb Vasc Biol, vol.20, pp.2024-2032, 2000.

M. Barbalic, J. Dupuis, and A. Dehghan, Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels, Hum Mol Genet, vol.19, pp.1863-72, 2010.